Example: Heart Attack

Clinical Trials on Hepatolenticular Degeneration

Total 33 results

NCT03334292

Recruiting

Natural History of Wilson Disease

Conditions: Wilson Disease
NCT04012658

Recruiting

A Registered Cohort Study on Wilson's Disease

Conditions: Wilson's Disease
NCT04573309

Recruiting

Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840

Conditions: Wilson Disease
NCT04212195

Recruiting

Cohort Research on Wilson's Disease

Conditions: Wilson's Disease
NCT01472874

Completed

Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease

Conditions: Wilson Disease
NCT04408300

Recruiting

Study of Retinal Vascular Parameters in Patients With Wilson's Disease

Conditions: Wilson Disease
NCT04531189

Recruiting

Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease

Conditions: Wilson Disease
NCT03299829

Completed

A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

Conditions: Trientine Treatment for Wilson's Disease
NCT03957720

Recruiting

The Individual Therapy for Patients With Wilson's Disease

Conditions: Wilson's Disease
NCT04537377

Not yet recruiting

A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease

Conditions: Wilson's Disease
NCT03867526

Completed

Establishment of Human Cellular Disease Models for Wilson Disease

Conditions: Wilson Disease
NCT04422431

Not yet recruiting

Copper Concentration and Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

Conditions: Wilson Disease
NCT03659331

Unknown status

A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease

Conditions: Wilson Disease
NCT03539952

Active, not recruiting

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Conditions: Wilson Disease
NCT02763215

Completed

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Conditions: Wilson Disease
NCT03403205

Active, not recruiting

Efficacy and Safety of ALXN1840 (Formerly Named WTX101) Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease With an Extension Period of up to 60 Months

Conditions: Wilson Disease
NCT02702765

Active, not recruiting

sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis

Conditions: Wilsons Disease
NCT02426905

Unknown status

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Conditions: Wilson Disease
NCT02273596

Completed

Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients

Conditions: Wilson Disease
NCT01874028

Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Conditions: Wilson's Disease
NCT00212355

Completed

Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Conditions: Wilson's Disease
NCT00004338

Completed

Study of Zinc for Wilson Disease

Conditions: Wilson Disease
NCT00004339

Completed

Study of Tetrathiomolybdate in Patients With Wilson Disease

Conditions: Wilson Disease
NCT03589820

Unknown status

Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure

Conditions: Wilson Disease; Liver Failure
NCT01378182

Completed

Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis

Conditions: Wilson's Disease